Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance (Q34075909)

30 July 2017

title

Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance (English)

1 reference

30 July 2017

0 references

0 references

1 reference

Mohsen Aarabi

3

0 references

author name string

Cyrus Ghobadi

1

1 reference

30 July 2017

Trevor N Johnson

2

1 reference

30 July 2017

Lisa M Almond

4

1 reference

30 July 2017

Aurel Constant Allabi

5

1 reference

30 July 2017

Karen Rowland-Yeo

6

1 reference

30 July 2017

Masoud Jamei

7

1 reference

30 July 2017

Amin Rostami-Hodjegan

8

1 reference

30 July 2017

publication date

1 December 2011

1 reference

Clinical Pharmacokinetics

30 July 2017

published in

1 reference

30 July 2017

volume

50

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

809-822

1 reference

So many studies, too few subjects: establishing functional relevance of genetic polymorphisms on pharmacokinetics

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Changes in liver volume from birth to adulthood: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Effects of obesity on pharmacokinetics implications for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Effect of obesity on the pharmacokinetics of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

What is the best size descriptor to use for pharmacokinetic studies in the obese?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Aminoglycoside dosing weight correction factors for patients of various body sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

The Simcyp population-based ADME simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Population-based mechanistic prediction of oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Prediction of intestinal first-pass drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Body surface area in normal-weight, overweight, and obese adults. A comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

The 3D scanner for measuring body surface area: a simplified calculation in the Chinese adult

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Cardiac function and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Relations of stroke volume and cardiac output to body composition: the strong heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Basal cardiac function and body composition with special reference to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

THE RELATION BETWEEN CARDIAC OUTPUT AND BODY SIZE

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Significant weight reduction in obese subjects enhances carbamazepine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Serum Inorganic Fluoride Levels in Obese Patients during and after Enflurane Anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and nonobese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Serum alpha 1-acid glycoprotein and the binding of drugs in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Microalbuminuria in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

The Sizes and Numbers of Cells in Visceral Organs in Human Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Glomerular number and size in relation to age, kidney weight, and body surface in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Estimation of creatinine clearance in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Dosing in obesity: a simple solution to a big problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Obesity and renal hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

The effects of weight loss on renal function in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Caffeine disposition in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Critique of the two-fold measure of prediction success for ratios: application for the assessment of drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Change in liver size and fat content after treatment with Optifast very low calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Body surface area and body weight predict total liver volume in Western adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

Assessment of inter-individual variability in predicted phenytoin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

A standard weight descriptor for dose adjustment in the obese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

A central body fat distribution is related to renal function impairment, even in lean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594420-000000000-00000

The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients

21 January 2018

1 reference

12 December 2020

A formula to estimate the approximate surface area if height and weight be known. 1916.

1 reference

12 December 2020

Halothane biotransformation in obese and nonobese patients.

1 reference

12 December 2020

Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity

1 reference

12 December 2020

Simplified calculation of body-surface area.

1 reference

12 December 2020

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

1 reference

12 December 2020

Phenytoin disposition in obesity. Determination of loading dose

1 reference

12 December 2020

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

1 reference

12 December 2020

Estimating creatinine clearance in morbidity obese patients

1 reference

12 December 2020

Body surface area prediction in normal-weight and obese patients

1 reference

12 December 2020

Glomerular filtration rate in severely overweight normotensive humans

1 reference

12 December 2020

Effect of age, gender, and obesity on midazolam kinetics.

1 reference

12 December 2020

Obesity, hyperinsulinemia, and portal blood flow. A theoretic study of the effects of increased portal blood flow upon fasting peripheral insulin concentrations

1 reference

12 December 2020

Pharmacotherapy for obesity

1 reference

12 December 2020

Modeling interindividual variation in physiological factors used in PBPK models of humans

1 reference

12 December 2020

Theophylline disposition in obesity

1 reference

12 December 2020

Oxygen uptake and cardiac performance in obese and normal subjects during exercise

1 reference

12 December 2020

Carbamazepine pharmacokinetics in obese and lean subjects.

1 reference

12 December 2020

Glomerular hyperfiltration in hypertensive African Americans

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Influence of obesity on drug disposition

1 reference

12 December 2020

Anesthetic Biotransformation and Renal Function in Obese Patients during and after Methoxyflurane or Halothane Anesthesia

1 reference

12 December 2020

Estimation of human body surface area from height and weight

1 reference

12 December 2020

The effects of portal shunts on intestinal cytochrome P450 3A activity

1 reference

12 December 2020

Central Fat MassVersusPeripheral Fat and Lean Mass: Opposite (AdverseVersusFavorable) Associations with Arterial Stiffness? The Amsterdam Growth and Health Longitudinal Study

1 reference

12 December 2020

Disparate cardiovascular effects of obesity and arterial hypertension

1 reference

12 December 2020

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

1 reference

12 December 2020

Rheological profile in severe and morbid obesity. Preliminary results

1 reference

12 December 2020

Disposition of enflurane in obese patients.

1 reference

12 December 2020

Systems clinical pharmacology

1 reference

12 December 2020

Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function

1 reference

12 December 2020

'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions

1 reference

12 December 2020

Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging

1 reference

12 December 2020

Comparison of different approaches to predict metabolic drug-drug interactions

1 reference

12 December 2020

Glomerular hemodynamics in severe obesity

1 reference

12 December 2020

A simple calculation to estimate body surface area in adults and its correlation with the Du Bois formula

1 reference

12 December 2020

Vancomycin dosing in morbidly obese patients

1 reference

12 December 2020

Effects of obesity on the cytochrome P450 enzyme system.

1 reference

12 December 2020

Modelling and simulation in prediction of human xenobiotic absorption, distribution, metabolism and excretion (ADME): in vitro-in vivo extrapolations (IVIVE)

1 reference

12 December 2020

The influence of age, sex, race, and body habitus on kidney weight in humans

1 reference

12 December 2020

Influence of lean body weight on anticancer drug clearance

1 reference

12 December 2020

Caffeine pharmacokinetics in obesity and following significant weight reduction

1 reference

12 December 2020

10.2165/11594420-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1015731657

0 references

1 reference